Penumbra, Inc. — Grafico, Quotazione e Notizie (NYSE:PEN)

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 12.52 B
Employee 4 700
Founded 2004
CEO Adam Elsesser
Website www.penumbrainc.com
Headquarter Delaware, United States
FIGI BBG001BP92V1
Industry Dispositivi Medicali

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

Rapporto prezzo/utili

68.79

Rapporto prezzo/fatturato

8.7

Penumbra, Inc. Common Stock

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

PEN

Financials

Penumbra, Inc. Common Stock

Notizie

Baron Health Care Fund Q1 2026 Portfolio Activity

Il titolo di Penumbra raggiunge il massimo a 52 settimane a $328,69

Diamond Hill Long-Short Strategy Q1 2026 Portfolio Movers: Gains, Drags, And Trades

Gli azionisti di Penumbra approvano la fusione con Boston Scientific Corp

Penumbra (PEN) Misses Q1 Earnings Estimates

ALC vs. PEN: Which Stock Should Value Investors Buy Now?

Utili di Penumbra sotto i riflettori mentre si avvicina l’accordo con Boston Scientific

NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry

3 Reasons Why Penumbra (PEN) Is a Great Growth Stock

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

Meitav Investment House lancia un’offerta pubblica per le azioni Peninsula

Here's Why Penumbra (PEN) is a Strong Growth Stock